EcoDrugPlus

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 1

Ensembl ID : ENSAPEG00000017280
Gene Symbol: AKR1B1.1
1 Cross references
350 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 2

Ensembl ID : ENSAPEG00000017222
Gene Symbol: AKR1B1.2
1 Cross references
348 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSAPEG00000011230
Gene Symbol: GAA
1 Cross references
233 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSAPEG00000003096
Gene Symbol: AOC1
1 Cross references
233 Possible Orthologues:

Amine Oxidase Copper Containing 2

Ensembl ID : ENSAPEG00000001276
Gene Symbol: AOC2
1 Cross references
402 Possible Orthologues:

Amyloid Beta (A4) Precursor Protein B

Ensembl ID : ENSAPEG00000001369
Gene Symbol: APPB
1 Cross references
205 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSAPEG00000003479
Gene Symbol: APP
2 Cross references
206 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSAPEG00000007289
Gene Symbol: AR
1 Cross references
214 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSAPEG00000017182
Gene Symbol: AGTR1
1 Cross references
203 Possible Orthologues:

Angiotensin Ii Receptor, Type 2

Ensembl ID : ENSAPEG00000009949
Gene Symbol: AGTR2
1 Cross references
189 Possible Orthologues:

Apelin Receptor 2

Ensembl ID : ENSAPEG00000007317
Gene Symbol: APLNR2
1 Cross references
172 Possible Orthologues:

Arachidonate 12-Lipoxygenase

Ensembl ID : ENSAPEG00000011165
Gene Symbol: ALOX12
1 Cross references
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).